STATINS AND MYOPATHY: MOLECULAR MECHANISMS
The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 application...
Main Authors: | O. M. Drapkina, E. M. Chernova, O. N. Korneeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-12-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/472 |
Similar Items
-
MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT
by: O. M. Drapkina, et al.
Published: (2015-09-01) -
The role of Coenzyme Q10 in statin-associated myopathy
by: Sanjay Kalra, et al.
Published: (2009-10-01) -
Pilot study of safety and efficacy of polyprenols in combination with coenzyme Q10 in patients with statin-induced myopathy
by: Gustavs Latkovskis, et al.
Published: (2016-01-01) -
Effects of statins on mitochondrial pathways
by: Hamid Mollazadeh, et al.
Published: (2021-04-01) -
Coenzyme Q10 for statin-induced myopathy : a systematic review
by: Pietersen, Lauren
Published: (2012)